PHARMACOKINETICS AND PK/PD MODELING OF AMOXICILLIN IN HUMAN MALE AND FEMALE VOLUNTEERS
Journal Title: WORLD JOURNAL PHARMACY AND PHARMACEUTICAL SCIENCE - Year 2018, Vol 7, Issue 7
Abstract
The present study aimed to investigate the pharmacokinetic behavior in terms of Pharmacokinetic(PK)/Pharmacodynamic (PD) Modeling of amoxicillin in human male and female volunteers. For this purpose, ten healthy, adult male and ten healthy adult females of 20-25 years of age were randomly selected. The detailed study procedure was told to the each human volunteer and consent was taken from each individual prior to the study. Amoxicillin (500 mg capsule) was administered orally to each volunteer. Blood samples were collected at specific time intervals. Plasma drug concentrations and time data was subjected to WinNonlin® for the estimation of pharmacokinetic parameters. Based upon the pharmacokinetic and pharmacodynamic data, PK/PD indices were estimated in order to optimize the dosage regimen of amoxicillin in humans. Student’s T-test was applied to observe the significant difference of the pharmacokinetic parameters between male and female human volunteer. P < 0.05 was considered as significant. Amoxicillin was well distributed in the body after its absorption as indicated by their respective AUC values in both male and female human volunteers. However, the drug was slowly eliminated (P < 0.05) in human female volunteers and stayed in the body for longer period of time as compared to human male volunteers. The values of PK/PD indices fall below the recommended values suggesting the individual dose optimization of amoxicillin in humans.
Authors and Affiliations
Dr. Zahid Manzoor
Keywords
Related Articles
- EP ID EP627408
- DOI -
- Views 144
- Downloads 0
PATENT STUDY FOR THE PROCESS OF SYNTHESIS OF GLICLAZIDE AND COMPOSITIONS WITH MODIFIED RELEASE CONTAINING THE SAME ACTIVE SUBSTANCE
Background: Sulfonylurea drugs are widely used for treatment of diabetes mellitus type 2 and from this group Gliclazide is mainly prescribed. The study aimed to summarize the available in ESPACENET database information f...
CHRONIC MYELOID LEUKEMIA PATIENT WITH ISOLATED CENTRAL NERVOUS SYSTEM BLAST CRISIS
The first therapeutic choice in Chronic Myeloid Leukemia (CML) is imatinib mesylate, a potent inhibitor of BCR / ABL tyrosine kinase. The blood brain barrier is poorly penetrated so that therapeutic concentrations in the...
RED CELL DISTRIBUTION WIDTH: A USEFUL MARKER OF DISEASE ACTIVITY IN INFLAMMATORY BOWEL DISEASE
Background and Objective: Studies concerning red cell distribution width (RDW) for use in the assessment of inflammatory bowel disease (IBD) activity are limited. We investigated whether RDW is a useful clinical marker o...
A REVIEW ON THE EXTRACTION METHODS USE IN MEDICINAL PLANTS, PRINCIPLE, STRENGTH AND LIMITATION
Medicinal plants are gaining much interest recently because their use in ethno medicine treating common disease such as cold, fever and other medicinal claims are now supported with sound scientific evidences. The study...
TRANSFUSION SUPPORT IN PATIENTS UNDERGOING AUTOLOGOUS HEMATOPOIETIC STEM CELLS: LITERATURE REVIEW
Hematopoietic stem cell transplantation is often the only cure for a patient. There are several obstacles that they face during the whole process of seeking a donor: the remission of the disease to enable the procedure,...